United Therapeutics Corporation (UTHR) Operating margin 2016–2025
United Therapeutics Corporation (UTHR) operating margin by fiscal year — reported operating income divided by reported revenue.
46.9%FY2025 · since FY2016: 66.4% → 46.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 46.9% | -1.0 pp |
| FY2024 | 47.9% | -3.1 pp |
| FY2023 | 50.9% | +0.3 pp |
| FY2022 | 50.6% | +17.6 pp |
| FY2021 | 33.0% | -7.0 pp |
| FY2020 | 40.0% | +53.0 pp |
| FY2019 | -12.9% | -62.4 pp |
| FY2018 | 49.5% | +2.2 pp |
| FY2017 | 47.2% | -19.2 pp |
| FY2016 | 66.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net incomeUTHR Net marginUTHR Gross profitUTHR Gross marginUTHR Operating incomeUTHR Operating cash flowUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total assetsUTHR Total liabilitiesUTHR Shareholders’ equityUTHR overview →